Related Experiment Videos
Cephalosporins in surgical prophylaxis
S Geroulanos1, K Marathias, J Kriaras
1Onassis Cardiac Surgery Center, Athens, Greece.
Journal of Chemotherapy (Florence, Italy)
|April 9, 2002
Summary
Antimicrobial prophylaxis before surgery significantly reduces infection rates, morbidity, and mortality. Single-dose cephalosporins, like cefazolin, are recommended, with specific guidelines for timing and drug choice to optimize patient outcomes.
Area of Science:
- Surgical infection prevention
- Clinical pharmacology
Background:
- Antimicrobial prophylaxis is proven to reduce surgical site infections, leading to better patient outcomes and reduced healthcare costs.
- Effective prophylaxis requires targeting likely pathogens with drugs present during and immediately after surgery.
Purpose of the Study:
- To review the evidence for antimicrobial prophylaxis in surgery.
- To provide recommendations on optimal drug selection, timing, and administration for surgical prophylaxis.
Main Methods:
- Review of controlled clinical trials and prospective randomized studies.
- Analysis of antimicrobial spectrum, pharmacokinetics, and clinical efficacy data.
Main Results:
- Single-dose antimicrobial prophylaxis initiated just before surgery is most effective and safe.
- First and second-generation cephalosporins (e.g., cefazolin, cefuroxime) are generally recommended.
- Third-generation cephalosporins are often used despite not being routinely recommended.
Conclusions:
- Optimal antimicrobial prophylaxis involves appropriate drug choice and precise timing, ideally a single preoperative dose.
- While cephalosporins are preferred, current practices show widespread use of third-generation agents.
- Adherence to evidence-based guidelines is crucial for effective surgical infection control.